All News ObsEva SA

Equities

OBSN

CH1260041939

End-of-day quote Swiss Exchange Other stock markets 23:00:00 28/04/2024 BST			5-day change	1st Jan Change
0.0072 ^CHF	-18.18%		+44.00%	-79.78%

04-03	ObsEva to Delist from the SIX Swiss Exchange	MT
03-20	ObsEva SA Announces to Wind-Down the Operations	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ObsEva to Delist from the SIX Swiss Exchange	04-03	MT
ObsEva SA Announces to Wind-Down the Operations	03-19	CI
ObsEva SA Announces Catarina Edfjäll to Step Down from the Board	03-19	CI
ObsEva to Wind Down, Flags SIX Swiss Delisting	02-28	MT
ObsEva Secures Temporary Moratorium Against Creditors	01-31	MT
ObsEva to File for Moratorium in Geneva, Switzerland	11-30	MT
ObsEva Announces Application for a Moratorium to Facilitate Pivotal Deals	11-30	AQ
ObsEva to Return Global Rights on Ebopiprant to Xoma	30/10/23	MT
Organon Returns Ebopiprant to XOMA	27/10/23	AQ
ObsEva Net Loss Narrows in H1	27/09/23	MT
ObsEva SA Reports Earnings Results for the Half Year Ended June 30, 2023	26/09/23	CI
ObsEva Terminates Licensing Deal with Yuyuan BioScience for Oral Oxytocin Receptor	13/07/23	MT
ObsEva Recovers Full Worldwide Rights on Nolasiban	13/07/23	AQ
ObsEva SA Announces Termination of Its Sub-Licensing Agreement with Yuyuan Bioscience	13/07/23	CI
SIX Group Makes Index Adjustments Following Review	12/07/23	MT
Switzerland's ObsEva Appoints Permanent CEO	02/05/23	MT
ObsEva SA announced that it expects to receive CHF 1.54 million in funding from ObsEva USA Inc.	07/12/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer